KCM
ABMD

Kingdon Capital Management’s Abiomed Inc ABMD Stock Holding History

Kingdon Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,930
Closed -$1.26M – 145
2015
Q4 		$1.26M Sell
13,930
-19,970
-59% -$1.69M 0.06% 109
2015
Q3 		$3.15M Sell
33,900
-41,100
-55% -$3.62M 0.15% 100
2015
Q2 		$4.93M Buy
+75,000
New +$4.98M 0.19% 97
2014
Q4 		– Sell
-83,900
Closed -$2.08M – 180
2014
Q3 		$2.08M Hold
83,900
– – 0.09% 143
2014
Q2 		$2.11M Buy
+83,900
New +$1.95M 0.08% 167

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Kingdon Capital Management's ABMD Position: Q1 2016 in Review

Kingdon Capital Management sold out of Abiomed Inc (ABMD) in Q1 2016, closing a stake of 13,930 shares — an estimated $1.26M sold.

Kingdon Capital Management first reported a position in ABMD in Q2 2014 and held it in 5 quarters. The position peaked at $4.93M in Q2 2015. 274 funds tracked by Wall St. Rank hold ABMD as of Q1 2016.

  • Kingdon Capital Management reported no remaining Abiomed Inc position as of Q1 2016 after selling out during the quarter.
  • Kingdon Capital Management sold 13,930 Abiomed Inc shares in Q1 2016, an estimated $1.26M.
  • Kingdon Capital Management first reported a position in Abiomed Inc in Q2 2014 and held it in 5 quarters.
  • Kingdon Capital Management's Abiomed Inc position peaked at $4.93M in Q2 2015.
  • 274 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2016.

Based on Kingdon Capital Management's 13F filing for Q1 2016, filed 16 May 2016.